{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:14:46Z","timestamp":1783401286807,"version":"3.54.6"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>As survivorship improves, second primary malignancies (SPMs) have become a clinically relevant late effect of localised breast cancer treatment. Evidence from the Middle East and Balkans is scarce, and contemporary data from T\u00fcrkiye are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We conducted a rigorous retrospective, multicentre cohort study within the Turkish Oncology Group across 14 tertiary centres. The medical records of 6, 552 women with early-stage breast cancer (2008\u20132022) were meticulously reviewed. SPMs were defined according to IARC\/SEER multiple-primary rules, and only the first SPM per patient was included. We calculated standardised incidence ratios (SIRs) with exact Poisson 95% confidence intervals (CIs) using age- and period-specific national female incidence rates averaged over the 2010\u20132020 period. Person-years were stratified by attained age and calendar period to ensure the accuracy and reliability of our results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 5.4 years (interquartile range, 1.1\u20139.4), 174 women developed pathologically confirmed SPMs. Breast cancer survivors had a significantly higher SPM risk compared to the general population (SIR, 1.66; 95% CI, 1.42\u20131.93). Excluding breast primaries, the excess remained (SIR 1.78; 95% CI, 1.51\u20132.09). The most significant increases were observed for thyroid cancer (SIR 7.09; 95% CI, 4.45\u201310.70) and sarcomas (SIR 7.14; 95% CI, 3.43\u201313.10), followed by ovarian (SIR 4.35; 95% CI, 2.58\u20136.89) and pancreatic cancers (SIR 4.08; 95% CI, 1.11\u201310.50). Risks for colorectal, brain, bladder, kidney, gastric, and contralateral breast cancers did not differ from expectations (all p&amp;gt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Turkish breast cancer survivors face a markedly increased SPM risk, especially for thyroid, sarcoma, and ovarian cancers. These findings should be interpreted cautiously in the context of treatment selection, surveillance intensity, hereditary predisposition, and regional background cancer risks. Prospective population-based studies incorporating detailed treatment exposures, germline testing, and standardized follow-up data are needed to clarify the mechanisms underlying these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1756315","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:22:58Z","timestamp":1783398178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group"],"prefix":"10.3389","volume":"16","author":[{"given":"Haydar Cagatay","family":"Yuksel","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvina","family":"Almuradova","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Can Hospital","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Buyukahiska","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ondokuz May\u0131s University Faculty of Medicine","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahiddin","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ondokuz May\u0131s University Faculty of Medicine","place":["Samsun, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Acar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Sahin","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Tunbekici","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"On","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet","family":"Akar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Manisa Celal Bayar University Faculty of Medicine","place":["Manisa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sahbazlar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Manisa Celal Bayar University Faculty of Medicine","place":["Manisa, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertugrul","family":"Bayram","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Cukurova University Faculty of Medicine","place":["Adana, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzeyyen Asli","family":"Ergozoglu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Cukurova University Faculty of Medicine","place":["Adana, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besire Nurdan","family":"Tazebay","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Kocaeli University Faculty of Medicine","place":["Kocaeli, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devrim","family":"Cabuk","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Kocaeli University Faculty of Medicine","place":["Kocaeli, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"Kitapli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Mugla Sitki Kocman University Faculty of Medicine","place":["Mugla, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedriye","family":"Acikgoz Yildiz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Pamukkale University Faculty of Medicine","place":["Denizli, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Afyonkarahisar Health Sciences University","place":["Afyonkarahisar, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Cosar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Afyonkarahisar Health Sciences University","place":["Afyonkarahisar, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Akin Telli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Demiroglu Bilim University and Group Florence Nightingale Hospital","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Faculty of Medicine, Sakarya University","place":["Sakarya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Hacibekiroglu","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Faculty of Medicine, Sakarya University","place":["Sakarya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teoman","family":"Sakalar","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Kahramanmara\u015f Necip Faz\u0131l City Hospital","place":["Kahramanmara\u015f, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nargiz","family":"Majidova","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Marmara University Faculty of Medicine","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Petrovska","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University Clinic for Radiotherapy and Oncology","place":["Skopje, North Macedonia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Celebi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Emin","family":"Kalender","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Meddem Hospital","place":["Isparta, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Rahman","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Tepecik Education and Research Hospital","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengiz","family":"Akosman","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Medicalpark Hospital","place":["Ordu, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudagul","family":"Danaci","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, \u0130n\u00f6n\u00fc University Faculty of Medicine","place":["Malatya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdinc","family":"Nayir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mersin Medical Park Hospital","place":["Mersin, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Gursoy","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Gokmen","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Ege University Faculty of Medicine","place":["Izmir, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/go.22.00354","article-title":"Improved survival of young patients with breast cancer 40 years and younger at diagnosis","volume":"9","author":"Saghir","year":"2023","journal-title":"JCO Global Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci Data"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.epi-25-1196","article-title":"Prevalence of cancer survivors in the United States","volume":"116","author":"Tonorezos","year":"2024","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.lanepe.2024.100903","article-title":"Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study","volume":"40","author":"Allen","year":"2024","journal-title":"Lancet Regional Health \u2013 Europe"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.bcd-24-0103","article-title":"Therapy-related myeloid neoplasms: complex interactions among cytotoxic therapies, genetic factors, and aberrant microenvironment","volume":"5","author":"Singhal","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.01146","article-title":"Second primary cancer risks after breast cancer in BRCA1 and BRCA2 pathogenic variant carriers","volume":"43","author":"Allen","year":"2025","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13058-023-01647-y","article-title":"Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort","volume":"25","author":"Ramin","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1094136","article-title":"Risk of second primary cancer among breast cancer patients: a systematic review and meta-analysis","volume":"12","author":"Parhizgar","year":"2022","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01610-x","article-title":"Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis","volume":"25","author":"Allen","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.0286","article-title":"Second primary breast cancer in young breast cancer survivors","volume":"10","author":"Brantley","year":"2024","journal-title":"JAMA Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/igc.0b013e3181a12e8b","article-title":"Second primary gynecologic cancers after breast cancer in Turkish women","volume":"19","author":"Gulhan","year":"2009","journal-title":"Int J Gynecological Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz203","article-title":"Follow-up care for breast cancer survivors","volume":"112","author":"Ruddy","year":"2020","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B14","unstructured":"Turkey Cancer Statistics Reports 2010\u20132020\n          \n          \n          \n          2025"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5152\/ejbh.2019.4890","article-title":"Breast cancer in Turkey; an analysis of 20,000 patients with breast cancer","volume":"15","author":"\u00d6zmen","year":"2019","journal-title":"Eur J Breast Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.06.001","article-title":"Lung cancer in Turkey","volume":"17","author":"Cang\u0131r","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4274\/tjcd.galenos.2025.2025-5-1","article-title":"Surgical and oncologic outcomes of colorectal cancer across age groups: a multicenter retrospective study from the Turkish Society of Colon and Rectal Surgery Registry","volume":"35","author":"Ahmet Ali","year":"2025","journal-title":"Turkish J Colorectal Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-201710001-00001","article-title":"Trends of gynecological cancers in Turkey: toward Europe or Asia","volume":"27","author":"Gultekin","year":"2017","journal-title":"Int J Gynecological Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13309","article-title":"Relationship of lymph node status with survival and recurrence among women with endometrial cancer","volume":"151","author":"Buldukoglu","year":"2020","journal-title":"Int J Gynecology Obstetrics"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.18663\/tjcl.751922","article-title":"Changes in the frequency of thyroid cancer and distribution of some subtypes in our region; retrospective analysis of 4917 thyroidectomies","volume":"11","author":"Ata\u015f","year":"2020","journal-title":"Turkish J Clinics Lab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5152\/ejbh.2019.4890","article-title":"Risk, molecular subtype and prognosis of second primary breast cancer: an analysis based on first primary cancers","volume":"13","author":"Li","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cson.2023.100010","article-title":"Breast radiation-associated secondary malignancies: a review","volume":"2","author":"Poland","year":"2023","journal-title":"Clin Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12679","DOI":"10.1038\/s41598-024-59209-x","article-title":"Risk factors for secondary thyroid cancer in patients with breast cancer: a propensity-matched SEER analysis","volume":"14","author":"Diao","year":"2024","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrae010","article-title":"Risk of thoracic soft tissue sarcoma after breast cancer radiotherapy: a population-based cohort study in Osaka, Japan","volume":"65","author":"Ikawa","year":"2024","journal-title":"J Radiat Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.942320","article-title":"Relationship between metastasis and second primary cancers in women with breast cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ygyno.2025.07.030","article-title":"Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant","volume":"201","author":"Apostol","year":"2025","journal-title":"Gynecol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.057","article-title":"Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain)","volume":"130","author":"Molina-Montes","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.43.2757","article-title":"Declining second primary ovarian cancer after first primary breast cancer","volume":"31","author":"Schonfeld","year":"2013","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0376-3","article-title":"Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study","volume":"118","author":"Martin","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5625","article-title":"Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era","volume":"5","author":"Morton","year":"2019","journal-title":"JAMA Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz010","article-title":"The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype","volume":"111","author":"Kramer","year":"2019","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B34","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ijc.34971","article-title":"Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors","volume":"155","author":"Brandt","year":"2024","journal-title":"Int J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35317","article-title":"The fraction of cancer attributable to modifiable risk factors in Turkey in 2018","volume":"156","author":"Tozduman","year":"2025","journal-title":"Int J Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5455\/annalsmedres.2024.07.154","article-title":"Trend analysis of thyroid carcinoma incidence: a retrospective analysis of 2,705 cases from an endemic goiter region","volume":"31","author":"Kocak","year":"2024","journal-title":"Ann Med Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1017\/s002193200700226x","article-title":"Prevalence and sociodemographic correlates of consanguineous marriages in Turkey","volume":"40","author":"Koc","year":"2008","journal-title":"J Biosocial Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s44162-022-00004-5","article-title":"The impact of consanguinity on human health and disease with an emphasis on rare diseases","volume":"1","author":"Temaj","year":"2022","journal-title":"J Rare Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2007.07.006","article-title":"Risk of cancer in an inbred population","volume":"31","author":"Denic","year":"2007","journal-title":"Cancer Detection Prev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2010.04.004","article-title":"Does consanguinity lead to decreased incidence of breast cancer","volume":"34","author":"Bener","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"B41","unstructured":"SEER*Explorer: an Interactive Website for SEER Cancer Statistics: Surveillance, Epidemiology, and End Results Program"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2017.93.6.287","article-title":"Development of second primary cancer in Korean breast cancer survivors","volume":"93","author":"Jung","year":"2017","journal-title":"Ann Surg Treat Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"103819","DOI":"10.1016\/j.breast.2024.103819","article-title":"The impact of fractionation on secondary malignancies in postoperative breast cancer irradiation","volume":"78","author":"Kiesl","year":"2024","journal-title":"Breast"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1756315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:23:07Z","timestamp":1783398187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1756315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":43,"alternative-id":["10.3389\/fonc.2026.1756315"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1756315","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"article-number":"1756315"}}